Application

STEP SEIZE THE TRUTH ABOUT EPILEPSY PERCEPTIONS

SK BIOPHARMACEUTICALS CO., LTD.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90078274
Filing Date: 07/28/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90078274
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\900\782\90078274\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT STEP Seize the Truth about Epilepsy Perceptions
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word STEP in stylized font above the words "Seize the Truth about Epilepsy Perceptions," and design of two people with overlapping speech balloons above their heads to the left of the word STEP.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 944 x 269
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK SK BIOPHARMACEUTICALS CO., LTD.
INTERNAL ADDRESS 221, Pangyoyeok-ro
*MAILING ADDRESS Bundang-gu, Seongnam-si,
*CITY Gyeonggi-do
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Korea, South
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
13494
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Korea, South
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical services in the field of epilepsy; providing medical information in the field of epilepsy prevention, screening, diagnosis and treatment; medical and pharmaceutical consultation relating to epilepsy; providing medical information in the field of epilepsy; medical information services in the field of epilepsy provided via the Internet ; medical consultancy for selecting appropriate medicines; health assessment services, namely, providing a database in the field of epilepsy information based on collected data; health care services, namely, providing a database in the field of epilepsy information and featuring inputting and collection of data and information all for treatment and diagnostic purpose; analysis of health information and data relating to epilepsy for medical diagnostic and medical treatment purposes; conducting medical information surveys in the field of epilepsy; conducting health assessment surveys in the field of epilepsy; providing medical information to patients and medical professionals in the form of reports in the field of epilepsy; medical analysis services for diagnosis, prognosis, symptoms and treatment of epilepsy; medical analysis services to facilitate the assessment of patient conditions and the development of personalized treatment protocols for patients with epilepsy; providing medical and pharmaceutical information in the field of epilepsy based on survey results; providing a web site featuring medical information; health care services, namely, disease management programs; medical information; health assessment services related to the responses to a health status survey; medical reporting of responses to a health status survey; providing information about epilepsy and its conditions, symptoms, detection, prevention and treatment, and information on patient health and experiences; providing a website for relay of information about patient experiences on health and treatment matters, and for patient support and community; conducting self-assessments of individual persons in the field of physical and mental health, featuring questions about access to health care services, health care costs, stabilities and access to food, housing and utilities, and personal independence, and compiling data related to all of the foregoing; health information analysis for medical diagnostic and medical treatment purposes.
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 11/01/2019
       FIRST USE IN COMMERCE DATE At least as early as 11/01/2019
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-69209791-20200727143 452293099_._step_evidence _of_use.pdf
       CONVERTED PDF FILE(S)
       (4 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\900\782\90078274\xml1\ APP0003.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\900\782\90078274\xml1\ APP0004.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\900\782\90078274\xml1\ APP0005.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\900\782\90078274\xml1\ APP0006.JPG
       SPECIMEN DESCRIPTION Company press release showing use of the mark with services
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT SK BIOPHARMACEUTICALS CO., LTD. is a corporation as organized under the laws of the Republic of Korea.
ATTORNEY INFORMATION
NAME Diane J. Mason
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Faegre Drinker Biddle & Reath LLP
STREET Four Embarcadero Center, 27th Floor
CITY San Francisco
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 94111
PHONE 415-591-7506
EMAIL ADDRESS sftrademarks@faegredrinker.com
DOMESTIC REPRESENTATIVE INFORMATION
NAME Diane J. Mason
FIRM NAME Faegre Drinker Biddle & Reath LLP
STREET Four Embarcadero Center, 27th Floor
CITY San Francisco
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP CODE 94111
PHONE 415-591-7506
EMAIL ADDRESS sftrademarks@faegredrinker.com
CORRESPONDENCE INFORMATION
NAME Diane J. Mason
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE sftrademarks@faegredrinker.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) sftrademarks@faegredrinker.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /djm/
SIGNATORY'S NAME Diane J. Mason
SIGNATORY'S POSITION Attorney of Record, California Bar
SIGNATORY'S PHONE NUMBER 415-591-7506
DATE SIGNED 07/28/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90078274
Filing Date: 07/28/2020

To the Commissioner for Trademarks:

MARK: STEP Seize the Truth about Epilepsy Perceptions (stylized and/or with design, see mark)
The literal element of the mark consists of STEP Seize the Truth about Epilepsy Perceptions. The applicant is not claiming color as a feature of the mark. The mark consists of the word STEP in stylized font above the words "Seize the Truth about Epilepsy Perceptions," and design of two people with overlapping speech balloons above their heads to the left of the word STEP.
The applicant, SK BIOPHARMACEUTICALS CO., LTD., a corporation of Korea, South, having an address of
      221, Pangyoyeok-ro
      Bundang-gu, Seongnam-si,
      Gyeonggi-do 13494
      Korea, South
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 044:  Medical services in the field of epilepsy; providing medical information in the field of epilepsy prevention, screening, diagnosis and treatment; medical and pharmaceutical consultation relating to epilepsy; providing medical information in the field of epilepsy; medical information services in the field of epilepsy provided via the Internet ; medical consultancy for selecting appropriate medicines; health assessment services, namely, providing a database in the field of epilepsy information based on collected data; health care services, namely, providing a database in the field of epilepsy information and featuring inputting and collection of data and information all for treatment and diagnostic purpose; analysis of health information and data relating to epilepsy for medical diagnostic and medical treatment purposes; conducting medical information surveys in the field of epilepsy; conducting health assessment surveys in the field of epilepsy; providing medical information to patients and medical professionals in the form of reports in the field of epilepsy; medical analysis services for diagnosis, prognosis, symptoms and treatment of epilepsy; medical analysis services to facilitate the assessment of patient conditions and the development of personalized treatment protocols for patients with epilepsy; providing medical and pharmaceutical information in the field of epilepsy based on survey results; providing a web site featuring medical information; health care services, namely, disease management programs; medical information; health assessment services related to the responses to a health status survey; medical reporting of responses to a health status survey; providing information about epilepsy and its conditions, symptoms, detection, prevention and treatment, and information on patient health and experiences; providing a website for relay of information about patient experiences on health and treatment matters, and for patient support and community; conducting self-assessments of individual persons in the field of physical and mental health, featuring questions about access to health care services, health care costs, stabilities and access to food, housing and utilities, and personal independence, and compiling data related to all of the foregoing; health information analysis for medical diagnostic and medical treatment purposes.

In International Class 044, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 11/01/2019, and first used in commerce at least as early as 11/01/2019, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Company press release showing use of the mark with services.

Original PDF file:
SPE0-69209791-20200727143 452293099_._step_evidence _of_use.pdf
Converted PDF file(s) (4 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4



Miscellaneous Statement
SK BIOPHARMACEUTICALS CO., LTD. is a corporation as organized under the laws of the Republic of Korea.


The owner's/holder's proposed attorney information: Diane J. Mason. Diane J. Mason of Faegre Drinker Biddle & Reath LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      Four Embarcadero Center, 27th Floor
      San Francisco, California 94111
      United States
      415-591-7506(phone)
      sftrademarks@faegredrinker.com

Diane J. Mason submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Diane J. Mason of Faegre Drinker Biddle & Reath LLP
      Four Embarcadero Center, 27th Floor
      San Francisco California 94111
      United States
      415-591-7506(phone)
      sftrademarks@faegredrinker.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.


The applicant's current Correspondence Information:
      Diane J. Mason
       PRIMARY EMAIL FOR CORRESPONDENCE: sftrademarks@faegredrinker.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sftrademarks@faegredrinker.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /djm/   Date: 07/28/2020
Signatory's Name: Diane J. Mason
Signatory's Position: Attorney of Record, California Bar
Payment Sale Number: 90078274
Payment Accounting Date: 07/28/2020

Serial Number: 90078274
Internet Transmission Date: Tue Jul 28 14:57:39 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.X.XX-202007281457397712
32-90078274-74023d25943f27d71bc6d781f88d
bdda6f6bdbbbc6da282f2039d3441e9a272f-CC-
57387183-20200728143124017285

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed